Lansoprazole
Product Images NDC 42254-331

4 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 42254-331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (152fb727 D516 441e A72b 33ddf1a325c1 01)

Structure (152fb727 D516 441e A72b 33ddf1a325c1 01)
Chemical structure diagram of lansoprazole, showing the molecular arrangement including a benzimidazole ring, sulfinyl group, and substituted pyridine ring.*
FDA Label Image

Figure1 (152fb727 D516 441e A72b 33ddf1a325c1 02)

Figure1 (152fb727 D516 441e A72b 33ddf1a325c1 02)
Line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients' showing the severity of heartburn on the y-axis (scale 0-3) and days from start of treatment on the x-axis (0 to 60). The graph compares placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD groups, illustrating a decrease in heartburn severity over time for both Lansoprazole dosages compared to placebo.*
FDA Label Image

Figure2 (152fb727 D516 441e A72b 33ddf1a325c1 03)

Figure2 (152fb727 D516 441e A72b 33ddf1a325c1 03)
A line graph showing the mean severity of night heartburn over days from the start of treatment for evaluable patients. It compares three groups: Placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, with severity rated from 0 (None) to 3 (Severe).*
FDA Label Image

Lansoprazole 15mg (152fb727 D516 441e A72b 33ddf1a325c1 04)

Lansoprazole 15mg (152fb727 D516 441e A72b 33ddf1a325c1 04)
Lansoprazole 15 mg DR Capsules label from Rebel Distributors Corp, showing NDC 42254-331-30. The label describes the product as delayed-release capsules containing 15 mg Lansoprazole USP as enteric-coated pellets. It includes product identifiers, manufacturer information (Dr. Reddy's Laboratories Limited, India), and storage instructions to keep medication out of reach of children and store at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.